Skip to main content
. Author manuscript; available in PMC: 2017 Aug 18.
Published in final edited form as: S Afr Med J. 2015 Apr 8;105(5):370–374. doi: 10.7196/SAMJ.8780

Table 3.

Predictors of poor outcomes in patients with bacteraemia*

Predictor, n (total N=59)* Outcome
OR (95% CI) p-value
Unimproved or died, n (%) Improved, n (%)
Incorrect empirical antibiotics (N=36) 17 (47.2) 19 (52.8) 8.05 (1.62 – 39.91) 0.004
Correct empirical antibiotics (N=20) 2 (10.0) 18 (90.0) 0.12 (0.03 – 0.62) 0.004
HIV+ (N=45) 11 (24.4) 34 (75.6) 0.75 (0.17 – 3.43) 0.99
HIV− (N=10) 3 (30.0) 7 (70.0) 1.32 (0.29 – 6.02) 0.99
HIV+ on ARVs (N=21) 6 (28.6) 15 (71.4) 0.74 (0.20 – 2.78) 0.74
HIV+ not on ARVs (N=20) 7 (35.0) 13 (65.0) 1.34 (0.36 – 5.04) 0.74
SBP ≤90 mmHg (N=10) 6 (60.0) 4 (40.0) 2.0 (0.46 – 8.70) 0.29
SBP >90 mmHg (N=38) 12 (31.6) 26 (68.4) 0.5 (0.115 – 2.17) 0.29
SIRS (N=40) 10 (25.0) 30 (75.0) 0.67(0.14 – 3.17) 0.68
No SIRS (N=9) 3 (33.3) 6 (66.7) 1.5 (0.32 – 7.14) 0.68
Salmonella bacteraemia (N=10) 2 (20.0) 8 (80.0) 0.43 (0.08 – 2.25) 0.47
Non-Salmonella bacteraemia (N=46) 17 (37.0) 29 (63.0) 2.34 (0.45 – 12.34) 0.47
S. aureus bacteraemia (N=17) 6(35.3) 11 (64.7) 1.09 (0.33 – 3.61) 1.0
Non-S. aureus bacteraemia (N=39) 13 (33.3) 26 (66.7) 0.92 (0.28 – 3.03) 1.0

SBP = systolic blood pressure; SIRS = systemic inflammatory response syndrome.

*

Cases of fungaemia (n=4) as opposed to bacteraemia were excluded from this analysis. Owing to missing data (5% of outcomes data, <5% of other variables), n for each characteristic does not add up to total N.